Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

被引:132
作者
Hohlbaum, AM
Gregory, MS
Ju, ST
Marshak-Rothstein, A
机构
[1] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Med, Arthrit Ctr, Boston, MA 02118 USA
[3] Schepens Eye Res Inst, Boston, MA 02114 USA
关键词
D O I
10.4049/jimmunol.167.11.6217
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas ligand (FasL) is a potent proapoptotic type-H transmembrane protein that can cause cell death in Fas(+) target populations. Despite the presumed "silent" nature of apoptotic cell death, forced expression of FasL can induce a dramatic inflammatory response. To elucidate the in vivo mechanism(s) linking FasL and inflammation, we used a membrane-bound cell-free form of FasL (mFasL-vesicle preparation (VP)). We found that i.p. injection of FasL-microvesicles led to the rapid activation and subsequent demise of Mac1(high) resident peritoneal macrophages. Apoptosis of Mac1(high) peritoneal macrophages was observed within 0.5 h of mFasL-VP injection and correlated with the detection of increased macrophage inflammatory protein (MIP)-2 levels in peritoneal lavage fluid as well as induced RNA expression of IL-1 beta, MIP-2, MIP-1 alpha, and MIP-1 beta. In vitro culture of purified peritoneal populations identified Mac1(high) cells as the major cytokine/chemokine producers in response to mFasL-VP. Purified Mac1(high) cells exposed to FasL could restore the ability of Fas-deficient mice to mount an inflammatory response. Our data demonstrate that the FasL-mediated inflammatory response starts with the production of proinflammatory mediators by preapoptotic resident tissue macrophages and suggest a general mechanism responsible for neutrophil inflammation seen in cases of FasL-expressing allografts.
引用
收藏
页码:6217 / 6224
页数:8
相关论文
共 50 条
[21]   Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells [J].
Kikuchi, H ;
Iizuka, R ;
Sugiyama, S ;
Gon, G ;
Mori, H ;
Arai, M ;
Mizumoto, K ;
ImajohOhmi, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (06) :778-783
[22]  
LEE J, 1992, J BIOL CHEM, V267, P16283
[23]   Differential regulation and function of Fas expression on glial cells [J].
Lee, SJ ;
Zhou, T ;
Choi, CH ;
Wang, Z ;
Benveniste, EN .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1277-1285
[24]  
MANTHEY CL, 1994, J IMMUNOL, V153, P2653
[25]   PURIFICATION AND CHARACTERIZATION OF A NOVEL MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR PRODUCED BY A HUMAN MYELOMONOCYTIC CELL-LINE [J].
MATSUSHIMA, K ;
LARSEN, CG ;
DUBOIS, GC ;
OPPENHEIM, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1485-1490
[26]  
McColl SR, 1999, J IMMUNOL, V163, P2829
[27]  
McDonald PP, 1999, J IMMUNOL, V163, P6164
[28]   Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand [J].
Miwa, K ;
Asano, M ;
Horai, R ;
Iwakura, Y ;
Nagata, S ;
Suda, T .
NATURE MEDICINE, 1998, 4 (11) :1287-1292
[29]  
Ottonello L, 1999, J IMMUNOL, V162, P3601
[30]   FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis [J].
Perlman, H ;
Pagliari, LJ ;
Georganas, C ;
Mano, T ;
Walsh, K ;
Pope, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1679-1688